Experimental Alzheimer’s drug may help kids with autism
NAP, developed in Israel, has proven effective in treating a mouse model of ADNP syndrome, a common genetic syndrome on the autism spectrum.
NAP, developed in Israel, has proven effective in treating a mouse model of ADNP syndrome, a common genetic syndrome on the autism spectrum.
Researchers find neuroprotective blood protein that is a biomarker for Alzheimer’s disease and also correlates with IQ.